| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| GV | - | Yes | - | Detail |
| LYFE Capital | - | Yes | - | Detail |
| Revelation Partners | - | Yes | - | Detail |
| Alexandria Venture Investments | - | - | - | Detail |
| ARCH Venture Partners | - | - | - | Detail |
| Bioverge | - | - | - | Detail |
| EDBI | - | - | - | Detail |
| Frazier Life Sciences | - | - | - | Detail |
| Lifeforce Capital | - | - | - | Detail |
| Medical Excellence Capital | - | - | - | Detail |
| Mirae Asset Capital | - | - | - | Detail |
| Newton Investment Management | - | - | - | Detail |
| NS Investment | - | - | - | Detail |
| OrbiMed | - | - | - | Detail |
| Section 32 | - | - | - | Detail |
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Apr 1, 2020 | Series A | $ 70M | ARCH Venture Partners,Domain Associates,etc. | Detail |
| Dec 12, 2019 | Seed | $ 6.50M | Alexandria Venture Investments,ARCH Venture Partners,etc. | Detail |